Oscar Health has announced Stock Purchase Agreements with Deerfield Management Company and the Anahata Foundation, a charity established by Oscar’s CEO Mark T. Bertolini. Deerfield plans to purchase 3 million shares of Oscar’s common stock and Anahata 2 million shares. The closing of the private placements is expected to occur on or around November 22, 2023.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
